Mally Parnes - Intelicanna CEO of the Company’s Subsidiary
| TEFN Stock | 62.00 0.30 0.49% |
CEO
Ms. Mally Bitzur Parnes was appointed Chief Executive Officer at a Subsidiary of Tefen Industrial Engineering Management And Systems Analysis Ltd. effective April 1, 2017. The Subsidiary is called Tefen Israel Ltd. Her work experience includes the following roles Head of Excellence Unit at Taas Systems and Vice presidentBusiness Development . She holds a BS degree in Industrial Engineering and Management Sciences. since 2017.
| Age | 35 |
| Tenure | 7 years |
| Phone | 972 3 977 5151 |
| Web | www.tefen.com |
Similar Executives
| Found 10 records | CEO Age | ||
| Ilana Primo | Analyst IMS Investment | 58 | |
| Boaz Rozman | Al Bad Massuot Yitzhak | 51 | |
| Scott Smith | Al Bad Massuot Yitzhak | 60 | |
| Itzhak Shenidovski | Analyst IMS Investment | 42 | |
| Ofer Lotan | Analyst IMS Investment | 49 | |
| Tzur Peleg | Analyst IMS Investment | 44 | |
| Uri Cinnamon | Gan Shmuel | 54 | |
| Alon Agoshbitz | Analyst IMS Investment | 49 | |
| Dan Mesika | Al Bad Massuot Yitzhak | 60 | |
| Tanbush Wolfgang | Al Bad Massuot Yitzhak | 58 | |
Intelicanna Leadership Team
Elected by the shareholders, the Intelicanna's board of directors comprises two types of representatives: Intelicanna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelicanna. The board's role is to monitor Intelicanna's management team and ensure that shareholders' interests are well served. Intelicanna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelicanna's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mally Parnes, CEO of the Company’s Subsidiary | ||
| Avraham Sadan, Independent Director | ||
| Erez Tova, CFO and Partner | ||
| Boaz Toshav, Independent Director | ||
| Moran Markovitz, Vice President - Finance | ||
| Ori Weiss, Chairman of the Board | ||
| Mor Balfour, Chairman of the Board | ||
| Elad Gazit, External Director | ||
| Naor Dribin, Vice President - Finance | ||
| Eliezer Pelleg, Executive Vice President | ||
| Yael NevoHirschenbein, Independent Director | ||
| Ayal Zylberman, Deputy CEO, Director | ||
| Doron Rozenblum, Internal Auditor | ||
| Saul Kaye, Director | ||
| Aharon Lichtenstein, CEO | ||
| Yona Levy, Director | ||
| Sharon Glazer, Director | ||
| Itzhak Malach, External Director | ||
| Zehavit ZivNer, External Director | ||
| Itay Rosenfeld, Director | ||
| Eyal Zilberman, Chairman of the Board | ||
| Nadia Whittley, Managing Director of Tefen Europe |
Intelicanna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intelicanna a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | (327.15) X | |||
| Revenue | 40.44 M | |||
| EBITDA | 2.29 M | |||
| Net Income | (24.63 M) | |||
| Cash And Equivalents | 1.04 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 1.84 M | |||
| Debt To Equity | 734.90 % | |||
| Current Ratio | 0.29 X | |||
| Book Value Per Share | (1.83) X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Intelicanna. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Intelicanna Stock analysis
When running Intelicanna's price analysis, check to measure Intelicanna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelicanna is operating at the current time. Most of Intelicanna's value examination focuses on studying past and present price action to predict the probability of Intelicanna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelicanna's price. Additionally, you may evaluate how the addition of Intelicanna to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |